Sartorius AG St receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sartorius AG DRC (SRT4y)
Sartorius AG DRC stock price live, this page displays F SRT4y stock exchange data. View the SRT4y premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Sartorius AG DRC real time stock price chart below.
What Is the Sartorius AG DRC Stock Price Today?
The Sartorius AG DRC stock price today is 46.00.
What Is the Stock Symbol for Sartorius AG DRC?
The stock symbol for Sartorius AG DRC is "SRT4y."
What Stock Exchange Does Sartorius AG DRC Trade On?
Sartorius AG DRC is listed and trades on the Frankfurt stock exchange.
Is Sartorius AG DRC a Good Stock to Buy?
Determining whether Sartorius AG DRC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SRT4y quote. (ISIN: US80385Q1094)
What Is the Sartorius AG DRC Stock Price Today?
The Sartorius AG DRC stock price today is 46.00.
What Is the Stock Symbol for Sartorius AG DRC?
The stock symbol for Sartorius AG DRC is "SRT4y."
What Stock Exchange Does Sartorius AG DRC Trade On?
Sartorius AG DRC is listed and trades on the Frankfurt stock exchange.
Is Sartorius AG DRC a Good Stock to Buy?
Determining whether Sartorius AG DRC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SRT4y quote. (ISIN: US80385Q1094)
46.00
+1.20(+2.68%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
46.00
46.00
52 wk Range
31.60
46.60
SRT4y is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
46.0046.00
52 wk Range
31.6046.60
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
SRT4y Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
- Sartorius AG St receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Sartorius AG St receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Sartorius AG DRC Earnings Call Summary for Q3/2026
- Sartorius reported 8.1% constant-currency sales growth in 9M 2026, with underlying EBITDA up 6.9% to €828M and free cash flow surging 55% to €310M.
- Company maintained full-year guidance at ~7% operational sales growth and >30% EBITDA margin, while raising Lab Products & Services outlook to upper end of range.
- Shares fell 2.36% to $41.4 despite solid results, as stock traded near 52-week high and investors awaited evidence growth can sustain through Q4 comparisons.
- Management highlighted equipment demand recovery and AI-driven drug discovery momentum, while implementing 'One Sartorius' restructuring for 2027 segment realignment.
- Tariff compensation and tougher Q4 comparisons pose near-term headwinds; net debt improved to 3.3x EBITDA from higher levels year-over-year.
Last Updated: 2026-10-22, 08:24 a/m
Read Full TranscriptEarnings
Latest Release
Oct 22, 2026
EPS / Forecast
-- / --
Revenue / Forecast
926.3M / --
Compare SRT4y to Peers and Sector
Metrics to compare | SRT4y | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSRT4yPeersSector | |
|---|---|---|---|---|
P/E Ratio | 82.1x | 33.3x | −0.2x | |
PEG Ratio | - | 0.86 | 0.00 | |
Price/Book | 6.1x | 2.7x | 2.6x | |
Price / LTM Sales | 4.9x | 3.8x | 2.8x | |
Upside (Analyst Target) | - | 4.6% | 60.9% | |
Fair Value Upside | Unlock | 1.5% | 9.5% | Unlock |
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products. It also provides lab filtration and purification solutions, lab water purification systems, microtissue technologies, lab weighing, pipettes, tips and dispensers, microbiological testing solutions, lab data and fleet management software, and OEM solutions; and Process chromatography and filtration solutions. The company serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Sartorius DRC (SRT4y) Stock Price Today?
The Sartorius DRC stock price today is 46.00 EUR.
What Stock Exchange Does Sartorius DRC Trade On?
Sartorius DRC is listed and trades on the Frankfurt Stock Exchange.
What Is the Stock Symbol for Sartorius DRC?
The stock symbol for Sartorius DRC is "SRT4y."
Does Sartorius DRC Pay Dividends? What’s The Current Dividend Yield?
The Sartorius DRC dividend yield is 0.2%%.
What Is the Sartorius DRC Market Cap?
As of today, Sartorius DRC market cap is 17.91B EUR.
From a Technical Analysis Perspective, Is SRT4y a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Sartorius DRC Stock Split?
Sartorius DRC has split 0 times.
How Many Employees Does Sartorius DRC Have?
Sartorius DRC has 14273 employees.
What is the current trading status of Sartorius DRC (SRT4y)?
As of Nov 10, 2026, Sartorius DRC (SRT4y) is trading at a price of 46.00 EUR, with a previous close of 44.80 EUR. The stock has fluctuated within a day range of 46.00 EUR to 46.00 EUR, while its 52-week range spans from 31.60 EUR to 46.60 EUR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.